1. Volume 15, Issue 4, Pages 478-484 (April 2018)
Dofetilide dose reductions and discontinuations in women compared with men 
Sean D. Pokorney, MD, MBA, Debbie C. Yen, PharmD, Kristen B. Campbell, PharmD, Nancy M. Allen LaPointe, PharmD, MHS, Shubin Sheng, MS, Laine Thomas, PhD, Tristram D. Bahnson, MD, FHRS, James P. Daubert, MD, FHRS, Jonathan P. Picini, MD, MHS, FHRS, Kevin P. Jackson, MD, Kevin L. Thomas, MD, Sana M. Al-Khatib, MD, MHS, FHRS 
Heart Rhythm 
Volume 15, Issue 4, Pages (April 2018)
DOI: /j.hrthm
Copyright © 2018 Heart Rhythm Society Terms and Conditions

2. Figure 1
Dofetilide discontinuations or dose reductions by sex. The P values represent the statistical difference between the prevalence in women and the prevalence in men.
Heart Rhythm  , DOI: ( /j.hrthm )
Copyright © 2018 Heart Rhythm Society Terms and Conditions

3. Figure 2
Dofetilide dose at discharge by sex. The bars represent the proportion of women and men who were discharged on the respective dofetilide doses. The doses are all twice daily doses.
Heart Rhythm  , DOI: ( /j.hrthm )
Copyright © 2018 Heart Rhythm Society Terms and Conditions